Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-07-18

Clinical Trial Update: Does Radioiodine Treatment Prevent Atrial Fibrillation and Bone Loss in Endogenous Subclinical Hyperthyroidism? [NA]

View source ↗

Summary

This clinical trial update discusses whether radioiodine treatment could prevent atrial fibrillation and bone loss in patients with endogenous subclinical hyper…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Iodine-131 (Iodine-131)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Hyperthyroidism | NA | Status: UNKNOWN